<?xml version="1.0" encoding="UTF-8"?>
<p>Current prevention and treatment options for SARS-CoV-2 infections are insufficient due to lack of approved drug therapy or vaccines [
 <xref rid="B10-molecules-25-03830" ref-type="bibr">10</xref>]. In a search for preventive and therapeutic options to counter threats of pandemics, the fundamental problem is that drug development is a costly, time-consuming and risky enterprise. Therefore, drug repurposing is a promising therapeutic strategy for many viral diseases and the most realistic in the present pandemic. Various predictive 
 <italic>in silico</italic> approaches have been applied to identify drug repositioning opportunities against SARS-CoV-2 [
 <xref rid="B10-molecules-25-03830" ref-type="bibr">10</xref>].
</p>
